Home
IPO Review by Dilip Davda
Menu
Home
Markets
IPO Review by Dilip Davda
India Inc
Economy and Politics
Intellect Views
Brands & Lifestyle
Pages
Home
IPO Review by Dilip Davda
Categories
Home
Markets
IPO Review by Dilip Davda
India Inc
Economy and Politics
Intellect Views
Brands & Lifestyle
Tag:
Research Society for the Study of Diabetes
India Inc
Lupin launches India’s first chatbot for patients
FI Online
—
November 23, 2018
comments off
Pharma major Lupin announced the launch of a chatbot named ‘ANYA’ specially designed to provide medically verified information for health-related queries. ANYA is the first bot of its kind to be launched...
Read more »